(Q57644643)

2

0 references

B Steger

3

0 references

L Scharinger

4

0 references

D Lederer

5

0 references

A Mayr

6

0 references

M Strasser

7

0 references

E Brunner

8

0 references

A Heuberger

9

0 references

F Hohla

10

0 references

J Steinwendner

11

0 references

W Patsch

12

0 references

C Datz

Journal of Internal Medicine

13

0 references

language of work or name

English

0 references

publication date

July 2011

0 references

published in

0 references

volume

270

0 references

issue

1

0 references

page(s)

41-9

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Genetic instability in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

A cohort study of the risk of cancer associated with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Colorectal cancer: another complication of diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Type 2 diabetes mellitus and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

The metabolic syndrome: insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

The advanced adenoma as the primary target of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Is metabolic syndrome a risk factor for colorectal adenoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Metabolic syndrome and risk of subsequent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Metabolic syndrome is associated with colorectal cancer in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Obesity and cancer: the role of dysfunctional adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02377.X